These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21994870)

  • 1. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.
    Uemura M; Fujimura Y; Ko S; Matsumoto M; Nakajima Y; Fukui H
    Int J Hepatol; 2011; 2011():759047. PubMed ID: 21994870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of ADAMTS13 in the progression of alcoholic hepatitis.
    Uemura M; Fujimura Y; Matsuyama T; Matsumoto M; Ishikawa M; Ishizashi H; Kato S; Tsujimoto T; Fujimoto M; Yoshiji H; Morioka C; Fukui H
    Curr Drug Abuse Rev; 2008 Jun; 1(2):188-96. PubMed ID: 19630717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal role of ADAMTS13 function in liver diseases.
    Uemura M; Fujimura Y; Ko S; Matsumoto M; Nakajima Y; Fukui H
    Int J Hematol; 2010 Jan; 91(1):20-9. PubMed ID: 20054668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.
    Uemura M; Fujimura Y; Matsumoto M; Ishizashi H; Kato S; Matsuyama T; Isonishi A; Ishikawa M; Yagita M; Morioka C; Yoshiji H; Tsujimoto T; Kurumatani N; Fukui H
    Thromb Haemost; 2008 Jun; 99(6):1019-29. PubMed ID: 18521503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases.
    Ko S; Okano E; Kanehiro H; Matsumoto M; Ishizashi H; Uemura M; Fujimura Y; Tanaka K; Nakajima Y
    Liver Transpl; 2006 May; 12(5):859-69. PubMed ID: 16528712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of ADAMTS13 to liver transplantation and surgery.
    Ko S; Chisuwa H; Matsumoto M; Fujimura Y; Okano E; Nakajima Y
    World J Hepatol; 2015 Jul; 7(13):1772-81. PubMed ID: 26167250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.
    Morioka C; Uemura M; Matsuyama T; Matsumoto M; Kato S; Ishikawa M; Ishizashi H; Fujimoto M; Sawai M; Yoshida M; Mitoro A; Yamao J; Tsujimoto T; Yoshiji H; Urizono Y; Hata M; Nishino K; Okuchi K; Fujimura Y; Fukui H
    Scand J Gastroenterol; 2008; 43(11):1387-96. PubMed ID: 18609162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.
    Takaya H; Namisaki T; Asada S; Iwai S; Kubo T; Suzuki J; Enomoto M; Tsuji Y; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Matsumoto M; Yoshiji H
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
    Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.
    Takaya H; Yoshiji H; Kawaratani H; Sakai K; Matsumoto M; Fujimura Y; Fukui H
    Biomed Rep; 2017 Sep; 7(3):277-285. PubMed ID: 28894574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score.
    Takaya H; Uemura M; Fujimura Y; Matsumoto M; Matsuyama T; Kato S; Morioka C; Ishizashi H; Hori Y; Fujimoto M; Tsujimoto T; Kawaratani H; Toyohara M; Kurumatani N; Fukui H
    Hepatol Res; 2012 May; 42(5):459-72. PubMed ID: 22292786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
    Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
    Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.
    Miodownik S; Pikovsky O; Erez O; Kezerle Y; Lavon O; Rabinovich A
    Am J Obstet Gynecol; 2021 Aug; 225(2):177.e1-177.e15. PubMed ID: 33621545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Uemura M; Matsuyama T; Ishikawa M; Fujimoto M; Kojima H; Sakurai S; Ishii S; Toyohara M; Yamazaki M; Yoshiji H; Yamao J; Matsumoto M; Ishizashi H; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):264S-71S. PubMed ID: 16385234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
    Manea M; Karpman D
    Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.